# Phase 102 Research Log

## 2026-10-11 — Phase initialization and source artifact review

- Created isolated branch `phase-102-final-strategy-ranking` from the Phase 101 branch to preserve the full prior evidence bundle.
- Reviewed the Phase 101 report and score summaries; read Phase 38 control/model comparison, Phase 50B TT-03 dynamic-N summary/split/terminal decision, Phase 51-3 TT-02/04/05 costed partial-window report, Phase 77 cluster-bootstrap report, Phase 78 temporal reconciliation, Phase 79 evidence gate, Phase 83 candidate gate/performance ledger, Phase 92 factor synthesis, Phase 95 forecast screen, Phase 96 SMA/EMA screen, and Phase 97–100 paper-method reports/manuscript.
- Confirmed the evidence must not be reduced to a raw-profit leaderboard: incompatible periods, sample sizes, drawdown units, methods and execution assumptions are present.
- Registered TT-03 as the first candidate for *further independent validation only*, not live use; hold split has 3 trades. TT-04/TT-05 are demoted by temporal instability despite short partial-window gains.
- Did not download market data, invoke external data APIs, tune parameters, or unseal any holdout data.
- Next: implement immutable scorecard, parser/arithmetic validations, unit tests, and GitHub Actions manual/push workflow.
- Initial source finding: all previous evidence is provisional in the different ways described in the scorecard; no current implementation satisfies every promotion gate.


## 2026-10-11 — Evidence register closed

- The scorecard, narrative report, validator, helper tests, workflow, validation JSON and final status have been committed to the Phase 102 branch.
- GitHub Actions [38082303704](https://github.com/vishnuvcr/Final-Stand-v5-1-1-1/actions/runs/38082303704): SUCCESS. The validator checked 14/14 source-artifact invariants; unit tests: 2/2. Machine-readable validation artifact uploaded.
- Three earlier failed runs were caused by brittle assertions against report text/decimal formatting and are documented as E102-004; these did not change the underlying research outcomes.
- Research stop reached. No candidate is approved for live use. TT-03 is a revalidation priority only, with new authorized exact-contract data and a sufficiently large independent holdout required before any new numerical phase. If those gates cannot be passed, stop at a documented no-go rather than repeat unchanged data searches.